Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV-1 and Hepatitis C Co-Infection”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Large-scale testing (Phase 3)Study completedNCT02073656
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 12 Weeks in Subjects With Chronic Genotype 1 or 4 HCV and HIV-1 Co-infection

Who this might be right for
Hepatitis C VirusHIV
Gilead Sciences 335
Large-scale testing (Phase 3)Study completedNCT02707601
What this trial is testing

Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment

Who this might be right for
HIV-1 InfectionHCV Infection
Gilead Sciences 150
Post-approval studies (Phase 4)UnknownNCT03549312
What this trial is testing

Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy

Who this might be right for
HIV-1-infectionHepatitis C, ChronicMethadone Dependence+6 more
Saskatchewan Health Authority - Regina Area 25
Not applicableEnded earlyNCT00340548
What this trial is testing

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

Who this might be right for
HemophiliaAIDS
National Cancer Institute (NCI) 333
Testing effectiveness (Phase 2)Study completedNCT00031343
What this trial is testing

The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon Alpha-2b and Ribavirin

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 128
Large-scale testing (Phase 3)Study completedNCT02738138
What this trial is testing

Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)

Who this might be right for
Hepatitis C Virus InfectionHuman Immunodeficiency Virus InfectionChronic Hepatitis C+1 more
AbbVie 153
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Testing effectiveness (Phase 2)WithdrawnNCT00121017
What this trial is testing

A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects

Who this might be right for
HIV InfectionHepatitis C
Abbott 200
Large-scale testing (Phase 3)Study completedNCT02480712
What this trial is testing

Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 107
Testing effectiveness (Phase 2)Study completedNCT01335529
What this trial is testing

Boceprevir in HIV-HCV Coinfected Patients Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin

Who this might be right for
HCV CoinfectionHIV-1 Infection
ANRS, Emerging Infectious Diseases 69
Testing effectiveness (Phase 2)Ended earlyNCT02194998
What this trial is testing

Evaluating the Safety and Effectiveness of Interferon-Free Treatment of Hepatitis C Virus Infection in HIV-Coinfected Adults on Antiretroviral Therapy

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 46
Testing effectiveness (Phase 2)Study completedNCT00983853
What this trial is testing

Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV

Who this might be right for
Hepatitis CHIV Infections
Vertex Pharmaceuticals Incorporated 62
Large-scale testing (Phase 3)Study completedNCT01513941
What this trial is testing

An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)

Who this might be right for
Chronic Hepatitis C
Janssen-Cilag International NV 163
Post-approval studies (Phase 4)Ended earlyNCT01443923
What this trial is testing

Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV

Who this might be right for
HepatitisHIV/AIDS
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableStudy completedNCT01423643
What this trial is testing

HCV/HIV Coinfection: Antiviral Therapy and Fibrosis

Who this might be right for
HIV InfectionHepatitis C
Johns Hopkins University 1,250
Not applicableEnrolling By InvitationNCT02699736
What this trial is testing

EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV

Who this might be right for
HIVHepatitis BHepatitis C+10 more
Rigshospitalet, Denmark 23,000
Large-scale testing (Phase 3)Study completedNCT01479868
What this trial is testing

Assess the Safety, Tolerability and Efficacy of TMC435 Along With Pegylated Interferon Alpha-2a (Pegasys) and Ribavirin (Copegus) Triple Therapy in Chronic Hepatitis C Genotype-1 Infected Patients Co-infected With Human Immunodeficiency Virus-Type 1

Who this might be right for
Hepatitis C Virus Genotype-1
Janssen R&D Ireland 109
Large-scale testing (Phase 3)Study completedNCT02071082
What this trial is testing

Efficacy and Safety of E/C/F/TAF (Genvoya®) in HIV-1/Hepatitis B Co-infected Adults

Who this might be right for
HIVHBV
Gilead Sciences 79
Testing effectiveness (Phase 2)Study completedNCT00665353
What this trial is testing

Pioglitazone Before Peginterferon and Ribavirin for Hepatitis C Infection in HIV/HCV-Coinfected Patients With Insulin Resistance

Who this might be right for
HIV-1 and Hepatitis C Co-Infection
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 19
Next Page